Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Apr 29
Love0

So Let’s Design a Peptide . . . A Physician’s Approach

By Chuck Lin No Comments
INTRODUCTIONThe extracellular matrix (ECM) is the foundational platform of the skin, incorporating the fibroblast cellular protein factory in a structural matrix of proteins that provide support to the dermis and…
Read More
Apr 29
Love0

Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK)

By Chuck Lin No Comments
INTRODUCTIONActinic keratoses (AKs) are epithelial lesions caused by ultraviolet radiation and cumulative sun exposure that have the potential to progress to invasive as squamous cell carcinoma (SCC) if left untreated.1-5…
Read More
Apr 22
Love0

Photodynamic Skincare: A Prospective Single-Center Study

By Chuck Lin No Comments
INTRODUCTIONThe cosmeceutical industry has produced countless new products to target signs of cutaneous aging, reduce acne, decrease hyperpigmentation, improve texture, and many other concerns. Peer-reviewed, clinical trials help inform the…
Read More
Apr 22
Love0

Eyebrow and Eyelash Loss in Patients With Cancer

By Chuck Lin No Comments
INTRODUCTIONHair loss is a detrimental side effect of cancer treatment, affecting up to 65% of patients.1 In addition to targeting hair follicles on the scalp, cancer treatments can also affect…
Read More
Apr 19
Love0

Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma

By Chuck Lin No Comments
INTRODUCTIONMelanoma is the fifth most common cancer in men and women in the United States (US), with an estimated 97,610 new cases in the year 2023.1 Although it accounts for…
Read More
Apr 19
Love0

Influence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes

By Chuck Lin No Comments
INTRODUCTIONMelanoma constitutes 3% of all skin cancers, but accounts for 65% of skin cancer deaths.1 The incidence of melanoma is increasing, with approximately 100,000 new diagnoses annually, of which more…
Read More
Apr 19
Love0

Beyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma Skin Cancers

By Chuck Lin No Comments
INTRODUCTIONSkin cancer is one of the most common malignancies worldwide and prevalence rates continue to rise each year.1 From 2007 to 2011, the United States spent an annual average of…
Read More
Apr 19
Love0

Postinflammatory Hyperpigmentation Following Mohs Micrographic Surgery: An Observational Study

By Chuck Lin No Comments
INTRODUCTIONPostinflammatory hyperpigmentation (PIH) is an acquired increase in melanin in response to inflammation or injury, including surgical intervention.1,2 PIH has been shown to have a significant impact on quality of…
Read More
Apr 19
Love0

The Use of Natural Therapies in Patients With Skin Cancer: A Scoping Review

By Chuck Lin No Comments
INTRODUCTIONSkin cancer is one of the most common malignancies in humans.1 There are 3 main categories of skin cancer, derived from the cell from which these cancers arise: basal cell…
Read More
Apr 17
Love0

The National Mentorship Match Algorithm: Mentors Needed

By Chuck Lin No Comments
INTRODUCTIONMentorship is a key factor for dermatology residency match success.1 However, dermatology mentor demand grossly exceeds supply, especially for dermatology residency applicants who are underrepresented in medicine (UIM) and/or without…
Read More
Apr 15
Love0

Skin Tone Representation on Patient-Facing Skin Cancer Education Websites

By Chuck Lin No Comments
INTRODUCTIONSkin self-examination (SSE) has been correlated with early detection of skin cancers; in one study over half of melanoma cases were self-recognized prior to diagnosis.1 Patients often reference photos from…
Read More
Apr 15
Love0

The Representation of Skin Tones in Google Images of Skin Cancers

By Chuck Lin No Comments
INTRODUCTIONSkin self-examinations (SSE) are an integral part of skin cancer surveillance, with the potential to reduce mortality from melanoma by 63%.1 Many patients rely on information found online, e.g. Google,…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors May 23, 2025
  • A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis May 22, 2025
  • Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study May 21, 2025
  • JDD in the News: Upadacitinib’s Potential Cardiovascular Effects  May 21, 2025
  • Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares May 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search